ePRO for the Timely Detection of Side Effects in Cancer Patients Undergoing CAR T Immunotherapy

Clinical trial NCT05354973 · UNKNOWN

Trial details

NCT number: NCT05354973
Sponsor: Stiftung Swiss Tumor Institute
Status: UNKNOWN
Study type: OBSERVATIONAL

Patient Reported Outcome Measures CAR T-Cell Therapy

Start date: 2022-03-21
Primary completion: 2025-04-30
Enrollment: 11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.